您要查找的是不是:
- Abstract: To investigate the effect of Mailuoning on platelet activity in the patients with chronic severe viral hepatitis (CSVH). 摘 要: 目的:探讨脉络宁对重型肝炎患者血小板活性的影响。
- The positive rate of HCV Ags expression was 45% (9/20) in severe viral hepatitis, 60% (6/10) in chronic severe hepatitis, 42.9% (3/7) in subacute severe hepatitis and 0%(0/3) in acute severe hepatitis. 肝组织内HCV抗原表达阳性率45%25(9/20),其中慢性重型肝炎60%25(6/10),亚急性42.;9(3/7),急性0%25(0/3)。
- chronic severe viral hepatitis B 乙型慢罩肝
- Chronic severe viral hepatitis 慢性重型病毒性肝炎
- Objective To explore the methonds of enhanced therapeutic effects for the early severe viral hepatitis (SVH). 摘要目的探讨提高早期重型病毒性肝炎(SVH)治疗效果的方法。
- Objective:To study the clinical value of prostaglandin E1(PGE1)in treating severe viral hepatitis. 目的:观察前列腺素E1(PGE1)治疗重型病毒性肝炎的临床疗效。
- The results indicated that the plasmatic pool size of Phe was increased and those of ECAA (Val, Leu, ILe) were decreased in severe viral hepatitis. 结果显示重型肝炎患者苯丙氨酸的血浆代谢库增大,而3种支链氯基酸的血浆库则减少。
- Methods A total of 83 patients including 66 with severe viral hepatitis were treated with ALSS using Baxter|550 artificial kidney and Biologic|DT system. 方法 利用Baxter 550人工肾和Biologic DTsystem进行人工肝支持系统 (ALSS)治疗肝炎患者 83例 ,其中重型肝炎患者66例。
- In order 10 correctly evaluate acid-base disturbances (ABD) in patients with severe viral hepatitis, 274 measurements of blood gases and electrolytes are analysed by the combination of ABD-PCF, AG, potential bicarbonate and chlorine (Cl~). 为正确诊断重型肝炎患者的酸碱失衡(ABD),作者联合运用ABD预计代偿公式(PCF)、阴离子隙(AG)、潜在HCO_3~-和血Cl~-分析了274例次血气分析和电解质测定参数。
- In order to correctly evaluate acid-base disorders (ABD) in patients with severe viral hepatitis, 223 parameters of measurements of blood gases are analysed through the use of preestimated compensatory formulas(PCF)and anion gap(AG) . 为了正确判断重型病毒性肝炎患者酸硷失衡(ABD),运用ABD预计代偿公式和阴离子隙(AG)分析了223例次血气分析参数。
- In order to evaluate the acid-hase disorders(ABD)in patients with severe viral hepatitis correctly,274 parameters of blood gas and electrolyte were analyzed. According to the combined analysis on the pre-estimated compensatory formula(PCF). 本文联合运用ABD预计代偿公式、阴离子隙、潜在HCO_3~-及Cl~-分析了274例次血气和电解质测定参数。
- Among the 223 measurements, alkalemia :acidemia = 3.23:1 . It indicates that alkalemia is the main change of ABD in patients with severe viral hepatitis and the prevention and treatment to alkalemia must be emphasized. 所有223例次中硷血症与酸血症之比为3.;23:1;表明硷血症是重型肝炎ABD的主要改变;必须强调硷血症的防治。
- The metabolic kinetics of branched chain amino acids (BCAA) and aromatic amino acids (AAA) in normal subjects and patients with severe viral hepatitis as studied with 4 stable isotope labeled tracers. 作者用4种稳定性核素标记的支链氨基酸和芳香氨基酸对正常人与重型病毒性肝炎(重型肝炎)患者进行示踪动力学的研究。
- Keywords plasma exchange;coloclyster;severe viral hepatitis;endotoxin; 血浆置换;结肠灌洗;重型肝炎;内毒素;
- TF correlates with the pathological stages of chronic viral hepatitis. TF与病毒性肝炎肝纤维化分期相关。
- Objective To observe the curative effect about soup of Cooling-blood promoting blood flow anti-aurigo treating viral hepatitis B severe chronic hyperbilirubinemia. 目的观察中医凉血活血退黄汤治疗乙型病毒性肝炎慢性重度高胆红素血症的疗效。
- Viral hepatitis leads to liver cell destruction. 病毒性肝炎导致肝细胞破坏。
- Objective To survey the mutuality of chronic severe hepatitis on peripheral blood cell and its results. 目的通过对慢性重型肝炎患者的外周血象分析,观察慢性重型肝炎的外周血象与其预后的相关性。
- Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver. 目的 应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝 ,进一步评价其安全性和疗效。
- Aim To observe the clinical therapeutic effects and adverse reaction of Lipo-PGE1 in treament of chronic severe hepatitis. 目的 观察前列腺素E1脂微球载体制剂 (凯时 ,Lipo PGE1)对慢性重症肝炎的治疗作用和副作用。